14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.71 $5.41 Wednesday, 24th Apr 2024 AUPH stock ended at $5.03. This is 1.18% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $5.00 to a day high of $5.16.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Sep 22, 2021 $23.10 $23.99 $22.36 $23.43 4 598 922
Sep 21, 2021 $21.01 $24.18 $20.79 $22.64 7 612 123
Sep 20, 2021 $19.99 $21.80 $19.86 $20.91 4 812 028
Sep 17, 2021 $19.31 $21.27 $19.25 $21.00 5 899 491
Sep 16, 2021 $20.62 $20.71 $18.74 $19.38 4 476 418
Sep 15, 2021 $21.17 $21.40 $20.26 $20.79 6 279 561
Sep 14, 2021 $20.92 $21.86 $20.72 $21.50 5 361 481
Sep 13, 2021 $19.68 $21.73 $19.07 $20.93 6 885 566
Sep 10, 2021 $19.46 $19.99 $18.55 $19.89 3 992 198
Sep 09, 2021 $19.00 $19.44 $18.86 $19.35 3 340 383
Sep 08, 2021 $18.32 $19.51 $17.94 $19.46 4 822 867
Sep 07, 2021 $17.53 $18.70 $17.53 $18.15 4 826 507
Sep 03, 2021 $17.50 $17.78 $17.20 $17.54 1 638 244
Sep 02, 2021 $16.90 $17.57 $16.73 $17.55 2 277 377
Sep 01, 2021 $16.39 $17.58 $16.36 $16.98 2 278 314
Aug 31, 2021 $16.96 $17.07 $16.14 $16.28 2 915 618
Aug 30, 2021 $17.80 $18.12 $16.53 $17.02 3 926 731
Aug 27, 2021 $18.12 $18.80 $17.26 $17.70 5 511 567
Aug 26, 2021 $16.26 $18.07 $15.29 $17.93 9 145 901
Aug 25, 2021 $15.14 $16.97 $15.11 $16.44 6 487 907
Aug 24, 2021 $14.46 $15.36 $14.00 $15.30 4 292 742
Aug 23, 2021 $14.14 $14.47 $13.83 $14.33 2 086 650
Aug 20, 2021 $12.97 $14.01 $12.96 $13.64 1 959 939
Aug 19, 2021 $12.97 $13.76 $12.88 $13.00 2 265 252
Aug 18, 2021 $13.22 $13.49 $12.71 $13.06 2 026 196
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT